Cerca de 130 casos de leishmaniose são registrados em 2021 no Maranhão globo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globo.com Daily Mail and Mail on Sunday newspapers.
Trial results show leishmaniasis vaccine is safe and induces immune responses in patients
The results of the first clinical trial of a new vaccine for a neglected tropical disease have demonstrated that it is safe and induces immune responses in patients with the infection.
There are currently no vaccines to prevent leishmaniasis which is spread by the bite of sand flies and existing drugs have many side effects and are difficult to administer.
The potential new vaccine was developed by researchers at the Hull York Medical School, which is the joint medical school of the Universities of Hull and York.
email article
Psoriasis continues to be the second largest contributor to skin-related disability globally, and its prevalence continues to increase. This chronic, disfiguring disease can have a significant negative impact on quality of life, especially in patients with a low socioeconomic status.
In its 2016 Global Report on Psoriasis, the World Health Organization (WHO) noted that psoriasis is estimated to affect at least 100 million adults and children worldwide, and that many people suffer needlessly due to missed or delayed diagnosis, poor access to care, inadequate treatment, and social stigmatization.
To better understand the global incidence, prevalence, and disease burden associated with psoriasis, investigators analyzed trends from 1990 to 2017 in 195 countries using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). The authors found a positive linear relationship between the prevalence of psoriasis and associated comorbidities incl